Sixty milligram daclatasvir is the right dose for hepatitis C virus treatment in combination with etravirine and darunavir/ritonavir

Saved in:
Bibliographic Details
Published inAIDS (London) Vol. 30; no. 9; pp. 1491 - 1493
Main Authors Smolders, Elise J, Kanter, Clara T.M.M de, Grintjes, Karin, D’Avolio, Antonio, Di Perri, Giovanni, van Crevel, Reinout, Drenth, Joost P.H, Burger, David M
Format Journal Article
LanguageEnglish
Published England Copyright Wolters Kluwer Health, Inc 01.06.2016
Subjects
AIDS/HIV
Anti-HIV Agents - administration & dosage
Anti-HIV Agents - therapeutic use
Antiviral Agents - administration & dosage
Antiviral Agents - therapeutic use
Area Under Curve
Coinfection - drug therapy
Darunavir - administration & dosage
Darunavir - therapeutic use
Diuretics - adverse effects
Drug Interactions
Hepatitis C, Chronic - drug therapy
HIV Infections - drug therapy
Humans
Imidazoles - administration & dosage
Imidazoles - therapeutic use
Male
Middle Aged
Pyridazines - administration & dosage
Pyridazines - therapeutic use
Renal Insufficiency - chemically induced
Ritonavir - administration & dosage
Ritonavir - therapeutic use
Treatment Outcome
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0269-9370
1473-5571
DOI:10.1097/QAD.0000000000001089